ThermoGenesisHoldingsInc . (NASDAQ:THMO) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 275,100 shares, an increase of 28.1% from the June 15th total of 214,800 shares. Currently, 6.9% of the shares of the company are short sold. Based on an average daily volume of 1,340,000 shares, the days-to-cover ratio is presently 0.2 days.
Several equities analysts have issued reports on THMO shares. Zacks Investment Research lowered ThermoGenesisHoldingsInc . from a “buy” rating to a “hold” rating in a report on Thursday, June 18th. ValuEngine raised ThermoGenesisHoldingsInc . from a “hold” rating to a “buy” rating in a report on Friday, May 1st. Finally, HC Wainwright raised their price objective on ThermoGenesisHoldingsInc . from $7.00 to $9.50 and gave the stock a “buy” rating in a report on Friday, April 17th.
An institutional investor recently bought a new position in ThermoGenesisHoldingsInc . stock. Renaissance Technologies LLC bought a new position in shares of ThermoGenesisHoldingsInc . (NASDAQ:THMO) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 183,261 shares of the company’s stock, valued at approximately $806,000. Renaissance Technologies LLC owned 6.44% of ThermoGenesisHoldingsInc . as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 3.14% of the company’s stock.
Shares of THMO traded up $0.07 during mid-day trading on Tuesday, hitting $5.27. 2,366 shares of the company’s stock were exchanged, compared to its average volume of 534,362. ThermoGenesisHoldingsInc . has a fifty-two week low of $1.63 and a fifty-two week high of $14.18. The firm has a market capitalization of $34.94 million, a P/E ratio of -1.20 and a beta of 3.36. The business’s 50 day moving average is $6.10 and its two-hundred day moving average is $5.30. The company has a current ratio of 2.07, a quick ratio of 1.42 and a debt-to-equity ratio of 1.19.
ThermoGenesisHoldingsInc . (NASDAQ:THMO) last announced its earnings results on Thursday, May 14th. The company reported ($1.11) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($1.10). ThermoGenesisHoldingsInc . had a negative return on equity of 273.55% and a negative net margin of 92.04%. The business had revenue of $3.20 million for the quarter, compared to analyst estimates of $5.40 million. On average, equities research analysts forecast that ThermoGenesisHoldingsInc . will post 0.17 earnings per share for the current year.
ThermoGenesisHoldingsInc . Company Profile
ThermoGenesis Holdings, Inc develops, commercializes, and markets a range of automated technologies for cell-based therapies in the United States, China, rest of Asia, Europe, and internationally. The company operates through two segments, Clinical Development and Device. It offers AutoXpress System, an automated system for the isolation, collection and storage of hematopoietic stem cell concentrates derived from cord blood and peripheral blood; Point-of CareXpress System for the rapid, automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells; CAR-TXpress System that addresses the critical unmet need for chemistry, manufacturing and controls improvement of the emerging CAR-T therapies for cancer patients; BioArchive Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for stem cell samples and clinical products; and manual disposables.
Featured Story: What are gap-down stocks?
Receive News & Ratings for ThermoGenesisHoldingsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ThermoGenesisHoldingsInc . and related companies with MarketBeat.com's FREE daily email newsletter.